참고문헌
- Alaiyan B, Ilyayev N, Stojadinovic A, et al (2013). Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence. BMC Cancer, 13, 196. https://doi.org/10.1186/1471-2407-13-196
- Arase M, Horiguchi K, Ehata S, et al (2014). Transforming growth factor-beta-induced lncRNA-Smad7 inhibits apoptosis of mouse breast cancer JygMC(A) cells. Cancer Sci, 105, 974-82. https://doi.org/10.1111/cas.12454
- Bao X, Wu H, Zhu X, et al (2015). The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters. Cell Res, 25, 80-92. https://doi.org/10.1038/cr.2014.165
- Cai JB, Shi GM, Dong ZR, et al (2014). Ubiquitin-specific protease 7 accelerates p14 degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression. Hepatol, [Epub ahead of print].
- Cao C, Sun J, Zhang D, et al (2015). The Long intergenic noncoding RNA UFC1, a target of MicroRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of beta-catenin in HCC cells. Gastroenterol, 148, 415-26 e18. https://doi.org/10.1053/j.gastro.2014.10.012
- Chen M, Therneau T, Orsini LS, et al (2011). Design and rationale of the HCC BRIDGE study in China: a longitudinal, multicenter cohort trial in hepatocellular carcinoma. BMC Gastroenterol, 11, 53. https://doi.org/10.1186/1471-230X-11-53
- Engreitz JM, Pandya-Jones A, McDonel P, et al (2013). The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome. Science, 341, 1237973. https://doi.org/10.1126/science.1237973
- Fang TT, Sun XJ, Chen J, et al (2014). Long non-coding RNAs are differentially expressed in hepatocellular carcinoma cell lines with differing metastatic potential. Asian Pac J Cancer Prev, 15, 10513-24.
- Flemming JA, Yang JD, Vittinghoff E, et al (2014). Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model. Cancer, 120, 3485-93. https://doi.org/10.1002/cncr.28832
- Gibb EA, Brown CJ, Lam WL (2011). The functional role of long non-coding RNA in human carcinomas. Mol Cancer, 10, 38. https://doi.org/10.1186/1476-4598-10-38
- Haerty W, Ponting CP (2015). Unexpected selection to retain high GC content and splicing enhancers within exons of multiexonic lncRNA loci. RNA, [Epub ahead of print].
- He X, Tan X, Wang X, et al (2014). C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion. Tumour Biol, 35, 12181-8. https://doi.org/10.1007/s13277-014-2526-4
- Hu X, Feng Y, Zhang D, et al (2014). A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. Cancer Cell, 26, 344-57. https://doi.org/10.1016/j.ccr.2014.07.009
- Kallen AN, Zhou XB, Xu J, et al (2013). The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell, 52, 101-12. https://doi.org/10.1016/j.molcel.2013.08.027
- Kam Y, Rubinstein A, Naik S, et al (2014). Detection of a long non-coding RNA (CCAT1) in living cells and human adenocarcinoma of colon tissues using FIT-PNA molecular beacons. Cancer Lett, 352, 90-6. https://doi.org/10.1016/j.canlet.2013.02.014
- Li GJ, Harrison TJ, Yang JY, et al (2013). Combined core promoter mutations and pre-S deletion of HBV may not increase the risk of HCC: a geographical epidemiological study in Guangxi, China. Liver Int, 33, 936-43. https://doi.org/10.1111/liv.12142
- Li Z, Rana TM (2014). Decoding the noncoding: prospective of lncRNA-mediated innate immune regulation. RNA Biol, 11, 979-85. https://doi.org/10.4161/rna.29937
- Ma MZ, Chu BF, Zhang Y, et al (2015). Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p. Cell Death Dis, 6, 1583. https://doi.org/10.1038/cddis.2014.541
- Mizrahi I, Mazeh H, Grinbaum R, et al (2015). Colon Cancer Associated Transcript-1 (CCAT1) Expression in Adenocarcinoma of the Stomach. J Cancer, 6, 105-10. https://doi.org/10.7150/jca.10568
- Spizzo R, Almeida MI, Colombatti A, et al (2012). Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene, 31, 4577-87. https://doi.org/10.1038/onc.2011.621
- Sun M, Liu XH, Lu KH, et al (2014). EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition. Cell Death Dis, 5, 1298. https://doi.org/10.1038/cddis.2014.256
- Uva P, Da Sacco L, Del Corno M, et al (2013). Rat mir-155 generated from the lncRNA Bic is 'hidden' in the alternate genomic assembly and reveals the existence of novel mammalian miRNAs and clusters. RNA, 19, 365-79. https://doi.org/10.1261/rna.035394.112
- Wu SC, Kallin EM, Zhang Y (2010). Role of H3K27 methylation in the regulation of lncRNA expression. Cell Res, 20, 1109-16. https://doi.org/10.1038/cr.2010.114
- Xiang JF, Yin QF, Chen T, et al (2014). Human colorectal cancerspecific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus. Cell Res, 24, 513-31. https://doi.org/10.1038/cr.2014.35
- Xing Z, Lin A, Li C, et al (2014). lncRNA directs cooperative epigenetic regulation downstream of chemokine signals. Cell, 159, 1110-25. https://doi.org/10.1016/j.cell.2014.10.013
- Yang F, Xue X, Bi J, et al (2013). Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma. J Cancer Res Clin Oncol, 139, 437-45. https://doi.org/10.1007/s00432-012-1324-x
- Zhu Z, Gao X, He Y, et al (2012). An insertion/deletion polymorphism within RERT-lncRNA modulates hepatocellular carcinoma risk. Cancer Res, 72, 6163-72. https://doi.org/10.1158/0008-5472.CAN-12-0010
피인용 문헌
- Long noncoding RNAs in digestive system cancers: Functional roles, molecular mechanisms, and clinical implications (Review) vol.36, pp.3, 2016, https://doi.org/10.3892/or.2016.4929
- Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing vol.37, pp.10, 2016, https://doi.org/10.1007/s13277-016-5227-3
- CCAT1: a pivotal oncogenic long non-coding RNA in human cancers vol.49, pp.3, 2016, https://doi.org/10.1111/cpr.12252
- Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis vol.12, pp.6, 2017, https://doi.org/10.1371/journal.pone.0179346
- CCAT1: an oncogenic long noncoding RNA in human cancers vol.143, pp.4, 2017, https://doi.org/10.1007/s00432-016-2268-3
- Long non-coding RNA CCAT1 is overexpressed in oral squamous cell carcinomas and predicts poor prognosis vol.6, pp.4, 2017, https://doi.org/10.3892/br.2017.876
- Persistent Exposure to Porphyromonas gingivalis Promotes Proliferative and Invasion Capabilities, and Tumorigenic Properties of Human Immortalized Oral Epithelial Cells vol.7, pp.2235-2988, 2017, https://doi.org/10.3389/fcimb.2017.00057
- Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells vol.9, pp.4, 2017, https://doi.org/10.3390/cancers9040038
- Long noncoding RNA HOTTIP promotes endothelial cell proliferation and migration via activation of the Wnt/β-catenin pathway pp.07302312, 2017, https://doi.org/10.1002/jcb.26448
- Downregulation of lncRNA CASC2 facilitates osteosarcoma growth and invasion through miR-181a pp.09607722, 2017, https://doi.org/10.1111/cpr.12409
- Current Status of Long Non-Coding RNAs in Human Breast Cancer vol.17, pp.9, 2016, https://doi.org/10.3390/ijms17091485
- Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets vol.140, pp.9, 2016, https://doi.org/10.1002/ijc.30546
- Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis vol.24, pp.5, 2018, https://doi.org/10.3748/wjg.v24.i5.549
- CX-3543 Promotes Cell Apoptosis through Downregulation of CCAT1 in Colon Cancer Cells vol.2018, pp.2314-6141, 2018, https://doi.org/10.1155/2018/9701957
- Identification of abnormally expressed lncRNAs induced by PM2.5 in human bronchial epithelial cells vol.38, pp.5, 2018, https://doi.org/10.1042/BSR20171577
- Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression vol.9, pp.1, 2018, https://doi.org/10.1038/s41467-018-06081-9
- : Roles and functions in human cancers pp.00219541, 2019, https://doi.org/10.1002/jcp.28176